Skip to content

A comparative study of Flumazenil versus Aminophylline on cognitive and neuromotor emergence after Isoflurane anesthesia.

A comparative study of Flumazenil versus Aminophylline on cognitive and neuromotor emergence after Isoflurane anesthesia.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT138801261815N1
Enrollment
90
Registered
2009-10-10
Start date
2007-06-01
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Volatile anesthetics. Inhaled anaesthetics

Interventions

Normal saline, 10cc was injected after discontinuation of Isoflurane
Intervention 1: Flumazenil 1mg was administered after discontinuation of Isoflurane. Intervention 2: Aminophylline 2mg/kg was administered after discontinuation of Isoflurane. Intervention 3: Normal s
Treatment - Drugs
Placebo
Flumazenil 1mg was administered after discontinuation of Isoflurane
Aminophylline 2mg/kg was administered after discontinuation of Isoflurane

Sponsors

Shiraz university of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
14 Years to 65 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: ASAI-II, age 14 to 65y/o, operation less than 3 hours Exclusion criteria: benzodiazepine ingestion within two weeks prior to the study, chronic benzodiazepine use, presence of respiratory and cardiovascular diseases, pregnancy, motor system dysfunction, renal and liver diseases, sensitivity to Flumazenil or benzodiazepine, ASAIII-IV, substance abuse or psychiatric problems

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Level of consciousness. Timepoint: 5-10-20-40-50-60minute after injection of drugs. Method of measurement: Asking from the patients.;Neuromotor emergence. Timepoint: 5-10-20-40-50-60minute after injection of drugs. Method of measurement: Examination.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Asef Parviz Kazemi

Shiraz University of Medical Sciences and Health Services

ap-kazemi@yahoo.com+98 71 1233 7636

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026